TLR3 and mesothelioma: In most preclinical and epidemiological studies, high TLR3 expression and/or activation is associated with a favorable prognosis, including in bladder cancer [22], mesothelioma [17], NSCLC [23], HCC [2], and breast cancer carcinoma [24].